Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility.
We performed a longitudinal analysis of 661 methicillin-resistant Staphylococcus aureus (MRSA) isolates obtained from patients in a long-term care facility. USA300 clone increased from 11.3% of all MRSA isolates in 2002 to 64.0% in 2006 (p<0.0001) and was mostly recovered from skin or skin structures (64.3% vs. 27.0% for non-USA300 MRSA; p<0.0001).
Tattevin
Pierre
P
Pontchaillou University Hospital, Rennes, France.
Diep
Binh An
BA
Jula
Michael
M
Perdreau-Remington
Françoise
F
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology / Q000635:transmission; D005260:Female; D006761:Hospitals; D006801:Humans; D008134:Long-Term Care; D008297:Male; D016106:Methicillin Resistance; D055624:Methicillin-Resistant Staphylococcus aureus / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012495:San Francisco / Q000453:epidemiology; D012867:Skin / Q000382:microbiology; D013207:Staphylococcal Skin Infections / Q000453:epidemiology* / Q000382:microbiology / Q000635:transmission
D000900:Anti-Bacterial Agents